US20060251596A1 - Deodorant agent - Google Patents

Deodorant agent Download PDF

Info

Publication number
US20060251596A1
US20060251596A1 US10/550,858 US55085805A US2006251596A1 US 20060251596 A1 US20060251596 A1 US 20060251596A1 US 55085805 A US55085805 A US 55085805A US 2006251596 A1 US2006251596 A1 US 2006251596A1
Authority
US
United States
Prior art keywords
odor
extract
ginkgo
phellodendron bark
deodorant agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/550,858
Other languages
English (en)
Inventor
Syunichi Akiba
Katsutoshi Ara
Hiroshi Kusuoku
Toyoki Hagura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of US20060251596A1 publication Critical patent/US20060251596A1/en
Assigned to KAO CORPORATION reassignment KAO CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HAGURA, TOYOKI, ARA, KATSUTOSHI, AKIBA, SYUNICHI, KUSUOKU, HIROSHI
Priority to US12/548,998 priority Critical patent/US8790726B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Definitions

  • This invention relates to deodorant agents, which inhibit the emission of human body malodors.
  • Body odors are given off from all over the body, led by sweat odor, (and including) bad breath, scalp odor, foot odor and the like. Concerning sweat odor among these odors, it is composed of an axillary odor typified by “hircismus” and an acid odor emitted from all over the body. In recent years, there is an increasing desire for the control of an axillary odor as a typical example of odor that causes feeling of disgust.
  • apocrine glands from which sweat is secreted as a source of an axillary odor are abundantly found at the axillae, the areolae, the pubes and the like. They are not found spreading widely and localized in these areas (for example, Pinkus H.; Mehregan A. H.; Adnexal Nevi and Benign Adnexoid Tumors, in A Guide to Dermatohistopathlogy; 2nd ed., pp 528, pp 29, by Appleton-Century-Crofts, New York, 1976).
  • a need continues to exist for the persistent elimination of such an axillary odor.
  • 3-methyl-2-hexenoic acid is a key odor molecule of apocrine sweat. This is secreted from apocrine glands in covered formby apolipoprotein D On the skin surface, this protein is decomposed by resident skin flora existing, and hence, an odor is generated (for example, Zeng C., et al., Proc. Natl. Acad. Sci. U.S.A., 93, 6626-6630, 1996).
  • ginkgo has blood flow promoting effects and anti-inflammatory effects
  • Phellodendron Bark has anti-inflammatory effects and intestinal function regulating effects. They are hence contained in Chinese herbal remedies, beverages and the like. It is, however, not known at all that they have an effect to inhibit body malodors.
  • An object of the present invention is to provide a deodorant agent which is high in safety and can radically inhibit the occurrence of human body malodors led by sweat odor, especially, axillary odor.
  • the present inventors were interested in the apocrine odor which is considered to be one of causative substances of human body malodors, and have proceeded with an investigation about inhibition of its formation. As a result, it has been found that certain particular plant extracts have an effect to inhibit the decomposition of apolipoprotein D, a carrier protein for odor molecules, by microorganisms resulting in reduction of malodors, and are useful substances capable of inhibiting the human body malodors.
  • the present invention provides a deodorant agent comprising, as an active ingredient, ginkgo or Phellodendron Bark or an extract thereof.
  • the present invention also provides use of ginkgo or Phellodendron Bark or an extract thereof for the production of a deodorant agent.
  • the present invention further provides a method for inhibiting a body malodor, which includes applying ginkgo or Phellodendron Bark or an extract thereof to the skin.
  • FIG. 1 is a diagram showing decomposition-inhibiting effects of a ginkgo extract for apolipoprotein D.
  • FIG. 2 is a diagram showing body-odor-inhibiting effects of the ginkgo extract.
  • FIG. 3 is a diagram showing decomposition-inhibiting effects of a Phellodendron Bark extract for apolipoprotein D.
  • FIG. 4 is a diagram showing body-odor-inhibiting effects of the Phellodendron Bark extract.
  • Ginkgo that can be used as a deodorant agent according to the present invention means Ginkgo biloba L. of the Ginkgoaceae family
  • Phellodendron Bark that can be used as a deodorant agent according to the present invention means Phellodendron amurens Ruprecht of the Rutaceae family.
  • ginkgo its leaves can be used either without modification or after grinding, with the use of leaves being preferred.
  • Phellodendron Bark on the other hand, the use of its bark is preferred.
  • extract of ginkgo or Phellodendron Bark means an extract in one of various solvents—which is obtained, for example, by extracting ginkgo leaves or Phellodendron Bark at room temperature or elevated temperature or extracting the same with an extraction apparatus such as Soxhlet extractor—its dilution, its concentrate, or its dried powder.
  • the extract can be a mixed extract obtained from two or more plants.
  • Examples of the solvent usable for extraction include water; alcohols such as methanol, ethanol, propanol and butanol; ketones such as acetone, methyl ethyl ketone; esters such as methyl acetate and ethyl acetate; linear and cyclic ethers such as tetrahydrofuran and diethyl ether; halogenated hydrocarbons such as dichloromethane, chloroform and carbon tetrachloride; hydrocarbons such as hexane, cyclohexane and petroleum ether; aromatic hydrocarbons such as benzene and toluene; polyethers such as polyethylene glycol; pyridines; oils and fats, such as soybean oil, rapeseed oil, squalane, isopropyl myristate, palmitic acid, oleic acid, and linoleic acid; and supercritical carbon dioxide. They can be used either singly or in combination.
  • low-polarity solvents such as ethanol, acetone, hexane, oils or fats, and supercritical carbon dioxide are preferred.
  • water-alcohol mixed solvents are preferred, with a water-ethanol mixed solvent being more preferred.
  • the content of ethanol can be preferably 50 v/v % or higher, more preferably 80 v/v % or higher, still more preferably 95 v/v % or higher.
  • Extraction conditions differ depending on the solvent to be used.
  • the extract can be used after removing inert impurities from it by a technique such as liquid-liquid partition, and the use of such an extract is preferred in the present invention. They can also be used after subjecting them to treatment such as deodorizing and/or decoloring as needed by method(s) known per se in the art.
  • the ginkgo or Phellodendron Bark extract can be used without modification as a deodorant agent according to the present invention.
  • the extract can also be used by diluting it or by concentrating or lyophilizing it and then preparing the concentrate or lyophilizate into a powder or paste-like form.
  • Ginkgo or Phellodendron Bark or an extract thereof as described above inhibits the decomposition of apolipoprotein D by microorganisms and inhibits the emission of body odors as will be demonstrated subsequently in examples.
  • causative substances (odor molecules) of human body odors primarily the apocrine odor which is a causative odor of axillary odor are considered to be branched, unsaturated lower fatty acids typified by 3-methyl-2-hexenoic acid (3M2H), and also that such odor molecules are included in carrier proteins and secreted into sweat by apocrine glands and the carrier proteins are then decomposed and liberated by microorganisms residing on the skin (Zeng C., et al., Proc.
  • apolipoprotein D is a carrier protein for the odor molecules, it is considered to be possible to inhibit the production of body odors if such decomposition of apolipoprotein D can be inhibited.
  • the production of body odors can be inhibited by applying ginkgo, Phellodendron Bark or an extract thereof to the skin in accordance with the present invention, and a preparation with ginkgo, Phellodendron Bark or an extract thereof contained in an effective amount therein can serve as a deodorant agent which could eradicate the production of such causative substances of odors.
  • the deodorant agent according to the present invention can be used as preparations such as cosmetics, external drug products and quasi-drug products, for example, creams, emulsions, lotions, powders, sprays, sticks, sheets, and plasters such as poultices. It is also possible to use two or more application methods in combination.
  • the content of ginkgo, Phellodendron Bark or an extract thereof upon using the deodorant agent according to the present invention as a cosmetic, external drug product or quasi-drug product can be set preferably at from 0.1 to 20 wt % in terms of dry weight basis in the composition, with from 0.5 to 10 wt % being preferred, and the content of the ginkgo or Phellodendron Bark extract can be set preferably at from 0.00001 to 10 wt % in terms of solid content basis in general, with from 0.0005 to 5 wt % being preferred.
  • external drug products or quasi-drug products for example, those generally used as cosmetic ingredients such as oils, surfactants, alcohols, chelating agents, pH adjusters, preservatives, viscosity increasing agents, colorants and fragrances, other ingredients such as ultraviolet absorbers, whitening agents, anti-wrinkle agents, humectants, sebum excretion inhibitors, emollients, keratin protecting agents, pharmaceutically-active agents, antioxidants and solvents can be added in a desired combination upon preparation.
  • cosmetic ingredients such as oils, surfactants, alcohols, chelating agents, pH adjusters, preservatives, viscosity increasing agents, colorants and fragrances
  • other ingredients such as ultraviolet absorbers, whitening agents, anti-wrinkle agents, humectants, sebum excretion inhibitors, emollients, keratin protecting agents, pharmaceutically-active agents, antioxidants and solvents can be added in a desired combination upon preparation.
  • the above-described preparations can each be provided with enhanced deodorant effects by adding finely-divided powder of a natural or synthesized, porous metal oxide, an astringent compound including a metal such as aluminum, zirconium or zinc as a component, a bactericidal agent, an antimicrobial agent, an antibiotic and/or the like as needed.
  • the deodorant agent according to the present invention can control the production of body odors by applying it to areas where malodors tend to occur, such as the feet, axillae, head and pubes.
  • the preparation can preferably be applied, for example, in an amount of from 1 to 20 mg in the case of a liquid preparation or in an amount of from 1 to 50 mg in the case of a solid preparation, per cm 2 of the skin, although it differs depending on the content of the active ingredient.
  • SDS-PAGE Sodium dodecyl sulfate polyacrylamide electrophoresis
  • Ready gel J separating gel concentration: 15%, Bio-Rad Laboratories, Inc.
  • RDI anti-apolipoprotein D monoclo
  • the apolipoprotein D in the sweat concentrate was decomposed and decreased.
  • the ginkgo extract or Phellodendron Bark extract By the addition of the ginkgo extract or Phellodendron Bark extract, however, the decomposition of apolipoprotein D was inhibited.
  • a solution which had been prepared by diluting the ginkgo extract to 10% concentration with 20% ethanol, was applied to one axillae of four subjects, and a control (20% ethanol, 0.5 g) was applied to the other axillae of the subjects, and axillary pads were worn in their both axillae. After seven hours, they entered an air-conditioned room of 40° C. and 75% RH and stayed there for 5 minutes. After eight hours, the axillary pads were collected, and an olfactory assessment was performed by a panel of three experts in accordance with the following standards, and the odor level was determined by an average of their scores. The results are shown in FIG. 2 .
  • the Phellodendron Bark extract prepared in Production Example 2 was concentrated to dryness, and then added to the ingredients shown below in Table 1 to give a solid content of 0.2%. Subsequently, a deodorant agent (stick) was prepared. By a similar method as in Example 2, its body odor inhibition effects were assessed. The results are shown in FIG. 4 .
  • TABLE 1 Ingredients % w/w Aluminum zirconium tetrachlorohydrate glycine 24.0 Cyclomethicone 54.8 Stearyl alcohol 15.0 Hydrogenated castor oil 5.0 Silica 1.0 Phellodendron Bark extract 0.2 Total 100.0
  • the deodorant agent according to the present invention can persistently inhibit the emission of human body malodors, and therefore, is useful as a material having excellent deodorizing effects and high safety.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
US10/550,858 2003-04-07 2003-09-19 Deodorant agent Abandoned US20060251596A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/548,998 US8790726B2 (en) 2003-04-07 2009-08-27 Deodorant agent

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003-103171 2003-04-07
JP2003103171A JP2004307396A (ja) 2003-04-07 2003-04-07 デオドラント剤
PCT/JP2003/011982 WO2004089324A1 (ja) 2003-04-07 2003-09-19 デオドラント剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/548,998 Division US8790726B2 (en) 2003-04-07 2009-08-27 Deodorant agent

Publications (1)

Publication Number Publication Date
US20060251596A1 true US20060251596A1 (en) 2006-11-09

Family

ID=33156818

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/550,858 Abandoned US20060251596A1 (en) 2003-04-07 2003-09-19 Deodorant agent
US12/548,998 Expired - Lifetime US8790726B2 (en) 2003-04-07 2009-08-27 Deodorant agent

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/548,998 Expired - Lifetime US8790726B2 (en) 2003-04-07 2009-08-27 Deodorant agent

Country Status (6)

Country Link
US (2) US20060251596A1 (zh)
EP (1) EP1616559B1 (zh)
JP (1) JP2004307396A (zh)
CN (1) CN1747715B (zh)
AU (1) AU2003264519A1 (zh)
WO (1) WO2004089324A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501136B2 (en) * 2003-09-30 2009-03-10 Kao Corporation Deodorant composition
CN102283869A (zh) * 2011-08-18 2011-12-21 王青 银杏提取物在制备治疗臭汗症的外用制剂中的用途
CN102349919B (zh) * 2011-08-18 2013-08-14 王青 银杏酚酸在制备治疗臭汗症的外用制剂中的用途
CN106176415A (zh) * 2016-08-23 2016-12-07 启东市生泰针织有限责任公司 一种体臭除臭剂
CN111733597B (zh) * 2020-06-02 2023-05-02 苏州工业园区安诺科斯化妆品研发有限公司 一种口罩除臭剂及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244662A (en) * 1990-12-04 1993-09-14 Korea Green Cross Corporation Medicinal extract from a mixture of phellodendron and defatted seed of croton, and method for it's manufacture
US5344648A (en) * 1990-08-16 1994-09-06 Iatron Laboratories, Inc. Central nervous system activator and taste enhancing food additive
US5468492A (en) * 1993-07-27 1995-11-21 Biogal Gyogyszergyar Rt Cosmetic composition
US6319523B1 (en) * 2000-06-29 2001-11-20 James H. Zhou Composition and method for inhibiting oral bacteria
US6551625B1 (en) * 1999-07-02 2003-04-22 Societe L'oreal S.A. Inhibiting disagreeable odors with extracts of undifferentiated plant cells
US20040047833A1 (en) * 2000-12-22 2004-03-11 Akihiro Ishino Hair growth inhibitors and compositions containing the same
US20050100520A1 (en) * 2003-09-30 2005-05-12 Kao Corporation Deodorant composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61103447A (ja) 1984-10-25 1986-05-21 松下電工株式会社 消臭剤
JP2600692B2 (ja) * 1987-07-10 1997-04-16 ライオン株式会社 消臭剤
JPH0231648A (ja) * 1988-07-21 1990-02-01 Daicel Chem Ind Ltd イチョウ抽出物入りチューインガム
JPH0669478B2 (ja) 1989-09-21 1994-09-07 松下電工株式会社 消臭剤および消臭スプレー
JP2505927B2 (ja) * 1990-12-25 1996-06-12 松下電工株式会社 シェ―バ―用消臭剤
CN1042799C (zh) 1993-03-03 1999-04-07 高贵 活血化瘀止痛膏
CN1051709C (zh) * 1993-08-04 2000-04-26 李社伦 雾化洁阴药剂
EP0681259B1 (en) 1994-04-28 2001-07-25 Sharp Kabushiki Kaisha Coordinate inputting apparatus and signal transmitting system thereof
JPH10158137A (ja) * 1996-11-26 1998-06-16 Maruzen Pharmaceut Co Ltd 脱臭剤
CN1202366A (zh) * 1997-06-13 1998-12-23 赵聚海 一种治疗汗脚的外用药
CN1055307C (zh) * 1998-03-24 2000-08-09 尹思源 脚病药皂
JP3902336B2 (ja) * 1998-07-27 2007-04-04 株式会社ノエビア 抗菌性植物抽出物、及びこれを含有する抗菌性皮膚外用剤
CN1253770A (zh) * 1998-11-18 2000-05-24 陈江辉 一种脚臭一次净及其制取方法
JP4733801B2 (ja) * 1999-08-23 2011-07-27 丸善製薬株式会社 エストロゲン様作用剤および皮膚化粧料
JP2002029954A (ja) * 2000-05-08 2002-01-29 Nippon Fine Chem Co Ltd 体臭抑制用組成物
JP2002003353A (ja) * 2000-06-19 2002-01-09 Kansai Koso Kk メチオナーゼ及び／又はプロテアーゼ阻害剤及び口腔用組成物
EP1352637B1 (en) 2000-12-22 2009-07-01 Shiseido Company, Ltd. Hair growth inhibitors and compositions containing the same
JP2002212877A (ja) * 2001-01-17 2002-07-31 Kankyo Kagaku Kaihatsu Kk 洗濯用消臭抗菌仕上げ剤および消臭抗菌付与方法
JP4577998B2 (ja) * 2001-01-24 2010-11-10 株式会社ヤクルト本社 尿酸値低下剤
JP2002226386A (ja) * 2001-01-30 2002-08-14 Rohto Pharmaceut Co Ltd 植物抽出物を含有する外皮用組成物
JP4723738B2 (ja) * 2001-03-01 2011-07-13 花王株式会社 デオドラント剤
FR2823116B1 (fr) * 2001-04-10 2004-11-19 Sod Conseils Rech Applic Procede de preparation d'une extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs
RU2003138141A (ru) * 2001-06-01 2005-06-10 Хенкель Кгаа (De) Ингибиторы арилсульфатазы в дезодорантах и антиперспирантах
JP2003113013A (ja) * 2001-09-28 2003-04-18 Lion Corp 植物性抗菌防腐剤
JP4703935B2 (ja) * 2002-04-01 2011-06-15 花王株式会社 アポリポプロテインｄ分泌抑制剤
US6548088B1 (en) * 2002-06-04 2003-04-15 Bih Cheng Chen Medicinal preparation for disinfecting vaginas

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344648A (en) * 1990-08-16 1994-09-06 Iatron Laboratories, Inc. Central nervous system activator and taste enhancing food additive
US5244662A (en) * 1990-12-04 1993-09-14 Korea Green Cross Corporation Medicinal extract from a mixture of phellodendron and defatted seed of croton, and method for it's manufacture
US5468492A (en) * 1993-07-27 1995-11-21 Biogal Gyogyszergyar Rt Cosmetic composition
US6551625B1 (en) * 1999-07-02 2003-04-22 Societe L'oreal S.A. Inhibiting disagreeable odors with extracts of undifferentiated plant cells
US6319523B1 (en) * 2000-06-29 2001-11-20 James H. Zhou Composition and method for inhibiting oral bacteria
US20040047833A1 (en) * 2000-12-22 2004-03-11 Akihiro Ishino Hair growth inhibitors and compositions containing the same
US20050100520A1 (en) * 2003-09-30 2005-05-12 Kao Corporation Deodorant composition
US7501136B2 (en) * 2003-09-30 2009-03-10 Kao Corporation Deodorant composition

Also Published As

Publication number Publication date
CN1747715B (zh) 2013-03-06
EP1616559A1 (en) 2006-01-18
US20090317346A1 (en) 2009-12-24
WO2004089324A1 (ja) 2004-10-21
EP1616559B1 (en) 2011-11-09
AU2003264519A1 (en) 2004-11-01
CN1747715A (zh) 2006-03-15
EP1616559A4 (en) 2007-01-17
JP2004307396A (ja) 2004-11-04
US8790726B2 (en) 2014-07-29

Similar Documents

Publication Publication Date Title
JP4532706B2 (ja) 化粧料
JP4723738B2 (ja) デオドラント剤
JP2001131046A (ja) 過酸化水素消去剤及びこれを含有する化粧料。
US8790726B2 (en) Deodorant agent
JP2005187474A (ja) 改善された香粧料
JP3170070B2 (ja) 皮膚外用剤
JP3415200B2 (ja) 皮膚外用剤
JP4703935B2 (ja) アポリポプロテインｄ分泌抑制剤
JP4212220B2 (ja) 体臭消臭剤
JP2006152003A (ja) デオドラント剤
JPH08175958A (ja) 皮膚外用剤
JP2000169329A (ja) 化粧料組成物
JP3809003B2 (ja) 美白剤
US20150374658A1 (en) Composition comprising licoricidine
KR102278167B1 (ko) 지질산화 방지, 자외선에 의한 손상 피부 개선 및 피부 진정 효과가 우수한 화장료 조성물
US6548052B2 (en) Antibacterial deodorizing compositions
JPH0450288B2 (zh)
KR20130103199A (ko) 졸음운전 방지용 조성물
JPH0640933A (ja) 抗炎症剤
KR100368126B1 (ko) 피지 분비 억제용 조성물
JPH01149706A (ja) 色白化粧料
JP4914538B2 (ja) 消臭剤とその用途
JPH06321760A (ja) 美白剤
KR102211761B1 (ko) 미네랄 복합체를 포함하는 체취 억제용 화장료 조성물 및 이의 제조방법
JP2005154365A (ja) デオドラント剤

Legal Events

Date Code Title Description
AS Assignment

Owner name: KAO CORPORATION, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:AKIBA, SYUNICHI;ARA, KATSUTOSHI;KUSUOKU, HIROSHI;AND OTHERS;REEL/FRAME:020019/0823;SIGNING DATES FROM 20050713 TO 20050719

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION